Hi Taureanbull,
I noticed you’d mentioned lots of patients dosed earlier with CheckVacc and Vaxinia.
If you don’t mind me chipping in I think Imugene has been clearing cohorts with the lowest number and then preceding to next cohort, so I think the numbers will be smaller than you’re expecting at the moment - basing this on the CheckVacc limited sample size to date, but makes sense not dosing more at the lower dose and going higher.
Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens, page-64
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $312.4M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.3¢ | 4.1¢ | $575.8K | 13.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 224495 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 3098596 | 22 |
View Market Depth
| Last trade - 14.22pm 19/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |